Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents

This publication has 16 references indexed in Scilit:

• Antimicrobial activity of tigecycline (GAR-936) tested against 3498 recent isolates of Staphylococcusaureus recovered from nosocomial and community-acquired infections
  International Journal of Antimicrobial Agents, 2004
• Tigecycline: a first in class glycylcycline
  Clinical Microbiology Newsletter, 2004
• Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002)
  Diagnostic Microbiology and Infectious Disease, 2004
• In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections
  Diagnostic Microbiology and Infectious Disease, 2004
• Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA
  Journal of Antimicrobial Chemotherapy, 2004
• In Vitro Activities of Tigecycline (GAR-936) against Multidrug-Resistant Staphylococcus aureus and Streptococcus pneumoniae
  Antimicrobial Agents and Chemotherapy, 2004
• In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum β-lactamases
  Diagnostic Microbiology and Infectious Disease, 2001
• The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting
  Chest, 2000
• Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates
  Diagnostic Microbiology and Infectious Disease, 2000
• Disk diffusion susceptibility test development for the new glycylcycline, GAR-936
  Diagnostic Microbiology and Infectious Disease, 1999